Dirk Bernicke
Roche Pharma AG (Germany)(DE)
Publications by Year
Research Areas
Angiogenesis and VEGF in Cancer, Glycosylation and Glycoproteins Research, Galectins and Cancer Biology, Cancer, Hypoxia, and Metabolism, Crystallization and Solubility Studies
Most-Cited Works
- → Ang-2-VEGF-A CrossMab, a Novel Bispecific Human IgG1 Antibody Blocking VEGF-A and Ang-2 Functions Simultaneously, Mediates Potent Antitumor, Antiangiogenic, and Antimetastatic Efficacy(2013)197 cited
- → Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts(2001)172 cited
- → Memory of Chirality in Electron Transfer Mediated Benzylic Umpolung Reactions of Arene-Cr(CO)3 Complexes(1999)58 cited
- → Rapid Activation of Bone Morphogenic Protein 9 by Receptor-mediated Displacement of Pro-domains(2015)41 cited
- → On the deprotonation of η6-1,3-dimethoxybenzene-Cr(CO)3 derivatives: Influence of the reaction conditions on the regioselectivity(1997)28 cited
- → Electron transfer driven reactions of transition metal π-complexes: Hydrogenation of styrene-Cr(CO)3 derivatives by samarium(II)iodide in the presence of water(1998)22 cited
- → Chiralitätstransfer bei der Elektronentransfer-getriebenen benzylischen Umpolung von Aren-Cr(CO)3-Komplexen(1999)19 cited
- → Highly Regioselective Benzylic Deprotonation of Some (η 6 ‐Tetralin)‐ and (η 6 ‐ trans ‐Octahydroanthracene)Cr(CO) 3 Derivatives: Is the Regioselectivity Stereoelectronically Controlled?(1998)11 cited
- → Data from Ang-2-VEGF-A CrossMab, a Novel Bispecific Human IgG1 Antibody Blocking VEGF-A and Ang-2 Functions Simultaneously, Mediates Potent Antitumor, Antiangiogenic, and Antimetastatic Efficacy(2023)1 cited
- → Supplementary Figure 2 from Ang-2-VEGF-A CrossMab, a Novel Bispecific Human IgG1 Antibody Blocking VEGF-A and Ang-2 Functions Simultaneously, Mediates Potent Antitumor, Antiangiogenic, and Antimetastatic Efficacy(2023)